Clinical Trial Update: MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

View source ↗

Summary

The MONITOR-CKD5 trial evaluating anemia treatment, outcomes, and determinants in chronic kidney disease stage 5 (end-stage renal disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Sandoz | Conditions: Chronic Kidney Disease, End-stage Renal Disease | Status: COMPLETED